Chief Commercial Officer (CCO)
Bernhard Schlichtner is Chief Commercial Officer and responsible for managing business development, sales, marketing and customer service at Single Use Support.
He owns a wide range of experience and knowledge into various and different industries such as aviation, automotive, manufacturing industry and biopharma, and multiple areas of activities due to his comprehensive and highly technical education and intensive insights.
Passionate for Automation, Engineering and Process Management Bernhard contributes to the innovative focus of Single Use Support. He joined the Tyrolean process solution provider in 2022 as Sales Application Engineer and has been promoted to Head of Business Development and now CCO.
December 20, 2022
The manufacturing process of biopharmaceuticals such as monoclonal antibodies, mRNA and bioconjugates is divided into upstream and downstream processing. Manufacturers seeking reliable automation and optimization fit for scale-up are increasingly employing single-use bioreactors, titers, filtration and other components, especially during upstream.
December 19, 2022
One would think that a sector like the fast-paced biomanufacturing industry could not get any faster. Yet, increased speed-to-market and ever more efficient manufacturing continue to drive product and process development. This is why single-use technologies have become increasingly popular. Read more about single-use systems for downstream processing in this article.
December 19, 2022
Upstream and downstream processing are two steps inherent to the production of active pharmaceutical ingredients (API) used in biopharmaceuticals. The production is challenged by increasing regulation and manufacturing costs. This calls for flexible solutions, which is why a growing number of manufacturing processes utilize single-use systems
November 8, 2022
Antibody-Drug Conjugates are rather novel and exciting biopharmaceutical agents. This article will give you an overview of what is to know about ADCs – find out more!
November 7, 2022
The antibody-drug conjugates (ADCs) market is expected to grow significantly in the next few years. But what are the key players in this competitive landscape? Find out more in this article!
May 18, 2022
Although autologous and allogeneic cell therapies share both defining methodological key elements as well as various fields of application, including most innovative cancer therapies, there are significant differences between them. Therefore, a closer look on both procedures shall be presented.
March 22, 2022
Gene therapy is a technique that modifies a person’s genes to treat or cure disease. Ex Vivo and In Vivo are two different approaches you will learn about in this article!
